Dr Arturo Vegas (Assistant Professor of Chemistry, Boston University Centre for Molecular Discovery, Boston, MA, US) explains the fundamentals of nanotechnology and how this can be applied to the treatment of type 1 and type 2 diabetes. He also discusses “smart” insulins, which are more glucose responsive. The use of these insulins would mean patients wouldn’t have to perform blood-sugar checks throughout the day. Dr Vegas hopes this would lead to improved long-term disease control. Finally, Dr Vegas briefly reviews the emergence of new therapies and technologies for the treatment of diabetes; he expects to see dramatic changes in the way we treat diabetes in the future.
1. What is nanotechnology? (0:13)
2. What are the latest advances in nanotechnology for the treatment of diabetes? (0:44)
3. How do you think the area of “Smart” (Gluco-Sensing) insulins will evolve over the next few years? (2:07)
4. What are your highlights from this year’s ADA meeting? (3:22)
Filmed at the American Diabetes Association (ADA) Annual Meeting, June 2018
Share this Video
Related Videos In Diabetes
Chantal Mathieu: Research highlights from 2022
We were delighted to speak with our editorial board member Prof. Chantal Mathieu (University Hospital Gasthuisberg Leuven, Leuven, Belgium) around this year’s research highlights in diabetes and what to look out for in 2023. Questions What are the key clinical highlights from 2022 in the field of diabetes? (0:16) What are the hot topics and […]
José García-Tirado, DTM 2022: RocketAP in Practice: Results from Pilot and Feasibility Trials
In this touchENDOCRINOLOGY interview, Dr José García-Tirado (University of Virginia, Charlottesville, VA, USA) gives an overview of RocketAP and discusses how the RocketAP compares to the USS-Virginia system and also what the next steps in the clinical development of the Rocket AP will be. The abstract entitled: ‘RocketAP in Practice: Results from Pilot and Feasibility […]
José García-Tirado, DTM 2022: Challenges in the development of artificial pancreas systems
An artificial pancreas is a system made of three parts that work together to mimic how a healthy pancreas controls blood glucose in the body. In this touchENDOCRINOLOGY interview, Dr José García-Tirado (University of Virginia, Charlottesville, VA, USA) discusses the major challenges in the development of artificial pancreas systems. The abstract entitled: ‘RocketAP in Practice: Results from Pilot […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!